Samin Mohsenian/LinkedIn
Jul 17, 2026, 09:42
Samin Mohsenian: Proud to Receive a Top Poster Award at ISTH 2026
Samin Mohsenian, Researcher at Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, shared on LinkedIn:
”It was a pleasure to present our latest findings on congenital Factor X deficiency at ISTH 2026.
In this work, we identified clinically relevant FX activity cut-offs that may support clinical decision-making and improve bleeding risk stratification.
We also explored the genotype–phenotype relationship, highlighting how genetic variants contribute to the clinical heterogeneity observed in patients.
I was also delighted that my poster on congenital Factor VII deficiency received a Top Poster Award.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 08:53Jamie’s Journey Through a Decade with Immune Thrombocytopenia – ITP Support Association
-
Sep 3, 2026, 08:00Beth Meneley: When Transfusion Is Not an Option – HBOT for Exceptional Blood Loss Anemia
-
Sep 3, 2026, 06:27Seyed Mehrab Safdari: Unmasking Factor VII Padua to Prevent Unnecessary Therapy and Thrombotic Risk
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease
-
Sep 3, 2026, 03:51Strengthening Bleeding Disorders Care in New Zealand – WFH
-
Sep 3, 2026, 03:42Nathan Connell: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia